Oxidative stress in twin neonates is influenced by birth weight and weight discordance

Clinical Biochemistry

Volumn 44, Issue 8-9, 2011, Pages 654-658

  Minghetti, Luisa ^a   Suppiej, Agnese ^b   Greco, Anita ^a   Franzoi, Malida ^b   Pascoli, Irene ^b   Zanardo, Vincenzo ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anti oxidant capacity; F2 isoprostane; Growth abnormalities; Oxidative stress; Prematurity; Twins

Indexed keywords

ISOPROSTANE DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BODY WEIGHT DISORDER; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; GROWTH DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE PREGNANCY; NEWBORN; OXIDATIVE STRESS; PREMATURITY; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; TWIN DISCORDANCE; UMBILICAL CORD BLOOD;

BIRTH WEIGHT; F2-ISOPROSTANES; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MALE; OXIDATIVE STRESS; PREGNANCY; TWINS;

EID: 79955874658     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.02.005     Document Type: Article

References (38)

1. Garite T.J., Clark R.H., Elliott J.P., Thorp J.A. Twins and triplets: the effect of plurality and growth on neonatal outcome compared with singleton infants. Am. J. Obstet. Gynecol. 2004, 191:700-707.
2. Cleary-Goldman J., D'Alton M.E. Growth abnormalities and multiple gestations. Semin. Perinatol. 2008, 32:206-212.
3. Blickstein I. Normal and abnormal growth of multiples. Semin. Neonatol. 2002, 7:177-185.
4. Einaudi M.A., Busuttil M., Monnier A.S., Chanus I., Palix C., Gire C. Neuropsychological screening of a group of preterm twins: comparison with singletons. Childs Nerv. Syst. 2008, 24:225-230.
5. Dennery P.A. Role of redox in fetal development and neonatal diseases. Antioxid. Redox Signal. 2004, 6:147-153.
6. Morrow J.D. The isoprostanes-unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Curr. Pharm. Des. 2006, 2:895-902.
7. Inder T., Mocatta T., Darlow B., Spencer C., Volpe J.J., Winterbourn C. Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr. Res. 2002, 52:213-218.
8. Ahola T., Fellman V., Kjellmer I., Raivio K.O., Lapatto R. Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Pediatr. Res. 2004, 56:88-93.
9. Longini M., Perrone S., Kenanidis A., Vezzosi P., Marzocchi B., Petraglia F., et al. Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. Free Radic. Biol. Med. 2005, 38:1537-1541.
10. Longini M., Perrone S., Vezzosi P., Marzocchi B., Kenanidis A., Centini G., et al. Association between oxidative stress in pregnancy and preterm premature rupture of membranes. Clin. Biochem. 2007, 40:793-797.
11. Baschat A.A. Pathophysiology of fetal growth restriction: implication for diagnosis and surveillance. Obstet. Gynecol. Surv. 2004, 59:617-627.
12. Luu T.M., Vohr B. Twinning on the brain: the effect on neurodevelopmental outcomes. Am. J. Med. Genet. C Semin. Med. Genet. 2009, 151C(2):142-147.
13. Rogers S., Witz G., Anwar M., Hiatt M., Hegyi T. Antioxidant capacity and oxygen radical diseases in the preterm newborn. Arch. Pediatr. Adolesc. Med. 2000, 154:544-548.
14. Burlingame J.M., Esfandiari N., Sharma R.K., Mascha E., Falcone T. Total antioxidant capacity and reactive oxygen species in amniotic fluid. Obstet. Gynecol. 2003, 101:756-761.
15. Minghetti L., Greco A., Rizzardi E., Pascoli I., Franzoi M., Zanardo V., et al. Oxidant injury in weight discordant twins measured by F2-isoprostane level in umbilical cord plasma. Eur J Paed Neurol 2009, 13:S31.
16. Greco A., Minghetti L., Puopolo M., Pietrobon B., Franzoi M., Chiandetti L., et al. Plasma levels of 15-F(2t)-isoprostane in newborn infants are affected by mode of delivery. Clin. Biochem. 2007, 40:1420-1422.
17. MacLennan A. Acute near-total intrauterine asphyxia. Pediatr. Neurol. 1999, 20:81-82.
18. Volpe J.J. Intracranial haemorrhage. Neurology of the newborn 2000, 428-493. WB Saunders Company, Philadelphia (PA). J.J. Volpe (Ed.).
19. De Vries L.S., Eken P., Dubowitz L.M.S. The spectrum of leukomalacia using cranial ultrasound. Behav. Brain Res. 1992, 49:1-6.
20. Merritt T.A., Deming D.D., Boynton B.R. The "new" bronchopulmonary dysplasia: challenges and commentary. Semin. Fetal Neonatal Med. 2009, 14:345-357.
21. Minghetti L., Greco A., Puopolo M., Combrinck M., Warden D., Smith A.D. Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease. J. Neuroinflammation 2006, 3:4.
22. Blickstein I., Kalish R.B. Birthweight discordance in multiple pregnancy. Twin Res. 2003, 6:526-531.
23. Engle W.A. A recommendation for the definition of "late preterm" (near-term) and the birth weight-gestational age classification system. Semin. Perinatol. 2006, 30:2-7.
24. Lee Y.M., Cleary-Goldman J., D'Alton M.E. Multiple gestations and late preterm (near-term) deliveries. Semin. Perinatol. 2006, 30:103-112.
25. Greco A., Minghetti L. Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases. Curr. Neurovasc. Res. 2004, 1:341-354.
26. Montuschi P., Barnes P., Roberts L.J. Insights into oxidative stress: the isoprostanes. Curr. Med. Chem. 2007, 14:703-717.
27. Powers W.F., Kiely J.L., Fowler M.G. The role of birth weight, gestational age, race and other infant characteristics in twin intrauterine growth and infant mortality. Multiple pregnancy 1995, 163-174. Parthenon Publishing, New York (NY). L.G. Keith, E. Papiernik-Berkhauer, D.M. Keith (Eds.).
28. Rooney R., Hay D., Levy F. Small for gestational age as a predictor of behavioral and learning problems in twins. Twin Res. 2003, 6:46-54.
29. Braekke K., Harsem N.K., Staff A.C. Oxidative stress and antioxidant status in fetal circulation in preeclampsia. Pediatr. Res. 2006, 60:560-564.
30. Wijnberger L.D., Krediet T.G., Visser G.H., van Bel F., Egberts J. Early neonatal antioxidant capacity after preexisting impaired placental function. Early Hum. Dev. 2003, 71:111-116.
31. Leitner Y., Fattal-Valevski A., Geva R., Eshel R., Toledano-Alhadef H., Rotstein M., et al. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study. J. Child Neurol. 2007, 22:580-587.
32. Simmons R.A. Developmental origins of adult disease. Pediatr Clin N Am 2009, 56:449-466.
33. Barker D.J. The origins of the developmental origins theory. J. Intern. Med. 2007, 261:412-417.
34. Trevisanuto D., Avezzù F., Cavallin F., Doglioni N., Marzolo M., Verlato F., et al. Arterial wall thickness and blood pressure in children who were born small for gestational age: correlation with umbilical cord high-sensitivity C-reactive protein. Arch. Dis. Child. 2010, 95:31-34.
35. Davies M.J. Fetal programming: the perspective of single and twin pregnancies. Reprod. Fertil. Dev. 2005, 17:379-386.
36. Gillman M.V. Developmental origins of health and diseases. N. Engl. J. Med. 2005, 353:1848-1850.
37. Vassalle C., Petrozzi L., Botto N., Andreassi M.G., Zucchelli G.C. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J. Intern. Med. 2004, 256:308-315.
38. Franco M.C., Kawamoto E.M., Gorjão R., Rastelli V.M., Curi R., Scavone C., et al. Biomarkers of oxidative stress and antioxidant status in children born small for gestational age: evidence of lipid peroxidation. Pediatr. Res. 2007, 62:204-208.